Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Purpose
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Conditions
- Chronic Low-back Pain
- Vertebrogenic Pain Syndrome
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU). - Signed a valid, IRB/EC-approved informed consent form.
Exclusion Criteria
- Meets any contraindications per locally applicable Instructions for Use (IFU).
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Intracept™ Intraosseous Nerve Ablation Systems | Subjects with pain treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System |
|
Recruiting Locations
Flagstaff Bone & Joint
Flagstaff, Arizona 86001
Flagstaff, Arizona 86001
Innovative Pain and Wellness
Phoenix, Arizona 85014
Phoenix, Arizona 85014
MarinHealth Spine Institute
Larkspur, California 94939
Larkspur, California 94939
Stanford University Medical Center
Stanford, California 94305
Stanford, California 94305
The Spine Wellness Center in Westport
Westport, Connecticut 06880
Westport, Connecticut 06880
Washington Hospital Center
Washington D.C., District of Columbia 20010
Washington D.C., District of Columbia 20010
Orlando Regional Medical Center
Orlando, Florida 32806
Orlando, Florida 32806
Horizon Clinical Research, LLC
Jasper, Georgia 30143
Jasper, Georgia 30143
Illinois Bone and Joint Institute
Barrington, Illinois 60010
Barrington, Illinois 60010
Commonwealth Pain and Spine
Lexington, Kentucky 40509
Lexington, Kentucky 40509
Ochsner Clinic Foundation
New Orleans, Louisiana 70115
New Orleans, Louisiana 70115
iSpine Clinics
Maple Grove, Minnesota 55369
Maple Grove, Minnesota 55369
CentraCare Health System
Saint Cloud, Minnesota 56303
Saint Cloud, Minnesota 56303
New York Spine and Pain Specialists
Port Jefferson Station, New York 11776
Port Jefferson Station, New York 11776
University of Rochester
Rochester, New York 14618
Rochester, New York 14618
Novant Health Spine Specialists
Bermuda Run, North Carolina 27106
Bermuda Run, North Carolina 27106
Allegheny General Hospital
Pittsburgh, Pennsylvania 15212
Pittsburgh, Pennsylvania 15212
Cy-Pain and Spine
Houston, Texas 77065
Houston, Texas 77065
University of Utah Orthopaedic Center
Salt Lake City, Utah 84108
Salt Lake City, Utah 84108
More Details
- Status
- Recruiting
- Sponsor
- Boston Scientific Corporation
Detailed Description
The objective of this study is to compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.